Repligen Corporation to Present at Barclays Global Healthcare Conference

Rhea-AI Summary

Repligen Corporation (NASDAQ:RGEN) will present at the Barclays Global Healthcare Conference from March 9-11, 2021. CFO Jon Snodgres is scheduled for a fireside chat on March 10 at 1:50 p.m. EST. A live webcast of this discussion will be available on the Company’s Investor Relations website and will be accessible for replay afterwards. Repligen specializes in innovative bioprocessing technologies for the biopharmaceutical industry, enhancing drug manufacturing efficiency globally.

WALTHAM, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the Barclays Global Healthcare Conference being held March 9-11. Jon Snodgres, Chief Financial Officer, will participate in a fireside chat on Wednesday, March 10, at 1:50 p.m. EST.

A live webcast of the discussion will be accessible through the Investor Relations section of the Company’s website, and will be available for replay for a limited period of time following the conference event.

About Repligen Corporation

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Our primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of our manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. we have sites in Estonia, Germany, Ireland, the Netherlands and Sweden.

Repligen Contact:
Sondra S. Newman
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com

FAQ

When is Repligen's presentation at the Barclays Global Healthcare Conference?

Repligen's presentation is scheduled for March 10, 2021, at 1:50 p.m. EST.

Who will represent Repligen at the Barclays Global Healthcare Conference?

Jon Snodgres, the Chief Financial Officer, will represent Repligen.

Where can I watch the Repligen presentation?

The presentation can be watched live on Repligen's Investor Relations website.

What is Repligen Corporation's focus in the biotech industry?

Repligen focuses on developing innovative bioprocessing technologies for efficient drug manufacturing.

What is the stock symbol for Repligen Corporation?

The stock symbol for Repligen Corporation is RGEN.